ES2192036T3 - Agentes anti-tumorales. - Google Patents
Agentes anti-tumorales.Info
- Publication number
- ES2192036T3 ES2192036T3 ES99909098T ES99909098T ES2192036T3 ES 2192036 T3 ES2192036 T3 ES 2192036T3 ES 99909098 T ES99909098 T ES 99909098T ES 99909098 T ES99909098 T ES 99909098T ES 2192036 T3 ES2192036 T3 ES 2192036T3
- Authority
- ES
- Spain
- Prior art keywords
- relates
- tumor
- benzoquinonyl
- tumor agents
- alkanoic acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 2
- 125000004154 1,4-benzoquinonyl group Chemical group C1(C(=CC(C=C1)=O)*)=O 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 150000007513 acids Chemical group 0.000 abstract 2
- 230000000259 anti-tumor effect Effects 0.000 abstract 2
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000002254 cytotoxic agent Substances 0.000 abstract 1
- 231100000599 cytotoxic agent Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 abstract 1
- 229960004961 mechlorethamine Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Agentes anti-tumorales. La invención se refiere a agentes citotóxicos anti-tumorales. Más particularmente, la invención se refiere a nuevos derivados de ácidos (1, 4-benzoquinonil)alcanoicos que llevan un sustituyente que comprende un resto citotóxico de mostaza nitrogenada. La invención se refiere también a procesos para la preparación de dichos derivados de ácidos (1, 4-benzoquinonil)alcanoicos, a composiciones farmacéuticas que los contienen y a su uso en la producción de un efecto anti-tumoral en un animal de sangre caliente tal como el hombre.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805868.8A GB9805868D0 (en) | 1998-03-20 | 1998-03-20 | Anti-tumour agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2192036T3 true ES2192036T3 (es) | 2003-09-16 |
Family
ID=10828860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99909098T Expired - Lifetime ES2192036T3 (es) | 1998-03-20 | 1999-03-16 | Agentes anti-tumorales. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6472435B1 (es) |
| EP (1) | EP1064257B1 (es) |
| JP (1) | JP2002507592A (es) |
| KR (1) | KR20010042056A (es) |
| CN (1) | CN1178900C (es) |
| AT (1) | ATE231836T1 (es) |
| AU (1) | AU746715B2 (es) |
| BR (1) | BR9908934A (es) |
| CA (1) | CA2319335A1 (es) |
| DE (1) | DE69905143T2 (es) |
| DK (1) | DK1064257T3 (es) |
| ES (1) | ES2192036T3 (es) |
| GB (1) | GB9805868D0 (es) |
| IL (1) | IL138590A (es) |
| NO (1) | NO20004663L (es) |
| NZ (1) | NZ506011A (es) |
| PT (1) | PT1064257E (es) |
| WO (1) | WO1999048860A1 (es) |
| ZA (1) | ZA200004386B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9805866D0 (en) | 1998-03-20 | 1998-05-13 | Zeneca Ltd | Anti-tumour agents |
| US6413533B1 (en) * | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
| US20060099712A1 (en) * | 2004-11-08 | 2006-05-11 | Eastman Kodak Company | Correlation of anti-cancer activity of dyes with redox potentials |
| WO2006099507A2 (en) * | 2005-03-11 | 2006-09-21 | Medical Instill Technologies, Inc. | Sterile de-molding apparatus and method |
| US20110039943A1 (en) * | 2005-03-14 | 2011-02-17 | Robert Alonso | Methods for treating skin disorders with topical nitrogen mustard compositions |
| US7872050B2 (en) * | 2005-03-14 | 2011-01-18 | Yaupon Therapeutics Inc. | Stabilized compositions of volatile alkylating agents and methods of using thereof |
| US8501818B2 (en) * | 2005-03-14 | 2013-08-06 | Ceptaris Therapeutics, Inc. | Stabilized compositions of alkylating agents and methods of using same |
| US8501817B2 (en) | 2005-03-14 | 2013-08-06 | Ceptaris Therapeutics, Inc. | Stabilized compositions of alkylating agents and methods of using same |
| WO2009035566A1 (en) * | 2007-09-07 | 2009-03-19 | The Board Of Supervisors Of Louisianana State University And Agricultural And Mechanical College | Redox-gated liposomes |
| KR101006166B1 (ko) * | 2008-12-10 | 2011-01-07 | 건국대학교 산학협력단 | 지하철 역 선로에 설치되는 자기성 분진 수거 장치 및 그 방법 |
| MX357284B (es) * | 2011-05-26 | 2018-07-04 | Univ Indiana Res & Tech Corp | Compuestos de quinona para tratar enfermedades mediadas por ape1. |
| US20140128398A1 (en) | 2011-06-03 | 2014-05-08 | Indiana University Research And Technology Corporation | Compounds, compositions and methods for treating oxidative dna damage disorders |
| WO2018053313A1 (en) * | 2016-09-19 | 2018-03-22 | Memorial Sloan-Kettering Cancer Center | Adenosine analogs as methyltransferase inhibitors for treating cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2862107D1 (en) * | 1977-12-02 | 1982-11-18 | Takeda Chemical Industries Ltd | Glucosamine-peptide derivatives and their pharmaceutical compositions |
| JPS58177934A (ja) | 1982-04-13 | 1983-10-18 | Takeda Chem Ind Ltd | ベンゾキノン誘導体 |
| NZ240785A (en) * | 1991-11-28 | 1995-08-28 | Cancer Res Campaign Tech | Substituted nitro aniline derivatives and medicaments |
| GB9805866D0 (en) | 1998-03-20 | 1998-05-13 | Zeneca Ltd | Anti-tumour agents |
-
1998
- 1998-03-20 GB GBGB9805868.8A patent/GB9805868D0/en not_active Ceased
-
1999
- 1999-03-16 US US09/646,464 patent/US6472435B1/en not_active Expired - Fee Related
- 1999-03-16 EP EP99909098A patent/EP1064257B1/en not_active Expired - Lifetime
- 1999-03-16 ES ES99909098T patent/ES2192036T3/es not_active Expired - Lifetime
- 1999-03-16 WO PCT/GB1999/000786 patent/WO1999048860A1/en not_active Ceased
- 1999-03-16 DK DK99909098T patent/DK1064257T3/da active
- 1999-03-16 PT PT99909098T patent/PT1064257E/pt unknown
- 1999-03-16 AT AT99909098T patent/ATE231836T1/de not_active IP Right Cessation
- 1999-03-16 CA CA002319335A patent/CA2319335A1/en not_active Abandoned
- 1999-03-16 AU AU28467/99A patent/AU746715B2/en not_active Ceased
- 1999-03-16 JP JP2000537845A patent/JP2002507592A/ja active Pending
- 1999-03-16 KR KR1020007010400A patent/KR20010042056A/ko not_active Ceased
- 1999-03-16 IL IL13859099A patent/IL138590A/en not_active IP Right Cessation
- 1999-03-16 BR BR9908934-3A patent/BR9908934A/pt not_active IP Right Cessation
- 1999-03-16 CN CNB998040908A patent/CN1178900C/zh not_active Expired - Fee Related
- 1999-03-16 NZ NZ506011A patent/NZ506011A/xx unknown
- 1999-03-16 DE DE69905143T patent/DE69905143T2/de not_active Expired - Fee Related
-
2000
- 2000-08-24 ZA ZA200004386A patent/ZA200004386B/en unknown
- 2000-09-19 NO NO20004663A patent/NO20004663L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010042056A (ko) | 2001-05-25 |
| ATE231836T1 (de) | 2003-02-15 |
| IL138590A0 (en) | 2001-10-31 |
| EP1064257A1 (en) | 2001-01-03 |
| EP1064257B1 (en) | 2003-01-29 |
| CN1178900C (zh) | 2004-12-08 |
| DK1064257T3 (da) | 2003-05-26 |
| US6472435B1 (en) | 2002-10-29 |
| AU746715B2 (en) | 2002-05-02 |
| WO1999048860A1 (en) | 1999-09-30 |
| DE69905143T2 (de) | 2003-11-20 |
| AU2846799A (en) | 1999-10-18 |
| DE69905143D1 (de) | 2003-03-06 |
| CN1293656A (zh) | 2001-05-02 |
| ZA200004386B (en) | 2002-01-30 |
| PT1064257E (pt) | 2003-06-30 |
| IL138590A (en) | 2004-08-31 |
| NO20004663D0 (no) | 2000-09-19 |
| CA2319335A1 (en) | 1999-09-30 |
| JP2002507592A (ja) | 2002-03-12 |
| NO20004663L (no) | 2000-11-13 |
| NZ506011A (en) | 2002-10-25 |
| BR9908934A (pt) | 2005-10-25 |
| GB9805868D0 (en) | 1998-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9304581A (es) | Desoxitaxoles y composiciones farmaceuticas que los contienen | |
| MX9308012A (es) | Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen. | |
| ES2058185T3 (es) | Derivados de camptotecina y procedimiento para su preparacion. | |
| ES2191320T3 (es) | Derivados de piperazina y su uso como agentes anti-inflamatorios. | |
| MX9300498A (es) | Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| PA8551001A1 (es) | Nuevos compuestos | |
| PT762896E (pt) | Composicoes de tocoferol para administracao de agentes biologicamente activos | |
| AR021811A1 (es) | Compuestos de piridina fusionados, utiles como inhibidores de gmpc fosfodiesterasa y las composiciones farmaceuticas que las contienen. | |
| PT910353E (pt) | Administracao transdermica de farmacos basicos utilizando sistemas adesivos naopolares e agentes de solubilizacao acidos | |
| GT199900070A (es) | Derivados de isotiazol, utiles como agentes anticancerosos. | |
| DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
| PT1093819E (pt) | Compostos e composicoes para fornecimento de agentes activos | |
| ECSP941104A (es) | Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| ITRM20010464A1 (it) | Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica. | |
| RU94029662A (ru) | Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения | |
| BG103518A (en) | 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives | |
| MX9301129A (es) | Nuevas ciclosporinas y composiciones farmaceuticas que las contienen. | |
| TR200101663T2 (tr) | Pro-kollajen c-proteinaz inhibitörleri | |
| PT989851E (pt) | Formulacao auto-emulsionante para compostos lipofilicos acidicos | |
| PA8582801A1 (es) | Nuevos derivados espirotricíclicos y su uso como inhibidores de la fosfodiesterasa | |
| DK0971717T3 (da) | Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler | |
| ES2178055T3 (es) | Derivados aminicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| MX9307011A (es) | Derivados hidrosolubles de camptotecina, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| GT199900154A (es) | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas. | |
| ATE297209T1 (de) | Podophyllotoxin-zusammensetzungen |